Company: NIVFW
Filing Date: 2025-05-29
Form Type: F-1/A
Source: 0001213900-25-048554
Chunk: 142

Company: NewGenIvf Group Ltd
Filing Date: 2025-05-29
Form: F-1/A
Chunk 142
---
) 326,609 shares underlying 
 the Exchange Warrants held by this Selling Shareholder.                                                                                |

| (8) | In accordance with the terms of the Registration                                                                                   
 Rights Agreement (as defined below) with this Selling Securityholder, for purposes of the calculations of ordinary shares to       
 be sold by this Selling Securityholder pursuant to the prospectus we are assuming (i) an event of default under the Fourth Tranche 
 Note and the Additional Remaining Notes has not occurred and the issuance of 250% of the ordinary shares underlying the Fourth     
 Tranche Note, assuming that (x) all Additional Notes issuable under the Securities Purchase Agreement (as defined below) have      
 been issued and (y) the Notes, including payment of 14.75% interest on the Notes through the fifty-four (54) month anniversary     
 of the issuance date of such Notes, are converted in full at an alternate conversion price of $0.2388 per share, without regard    
 to any limitations set forth therein and (ii) the issuance of the maximum amount of ordinary shares underlying the Warrants,       
 exercised in full at the applicable exercise price without regard to any limitations set forth therein.                            |

92 PLAN OF DISTRIBUTION We are registering the Class A Ordinary Shares previously issued and the Class A Ordinary Shares issuable upon conversion of the Notes and exercise of the Warrants, to permit the resale of these Class A Ordinary Shares by the holders of these securities from time to time after the date of this prospectus. We will not receive any of the proceeds from the sale by the Selling Securityholders of the Class A Ordinary Shares, although we will receive (i) the exercise price of any Warrants not exercised by the Selling Securityholders on a cashless exercise basis, and (ii) gross proceeds of up to $500 million from the sale of our Class A Ordinary Shares to White Lion pursuant to the White Lion Purchase Agreement. We will bear all fees and expenses incident to our obligation to register the Selling Securityholder’s Class A Ordinary Shares. The Selling Securityholders may sell all or a portion of the Class A Ordinary Shares held by them and offered hereby from time to time directly or through one or more underwriters, broker-dealers or agents. If the Class A Ordinary Shares are sold through underwriters or broker-dealers, the Selling Securityholders will be responsible for underwriting discounts or commissions or agent’s commissions. The Class A Ordinary Shares may be sold in one or more transactions at fixed prices, at prevailing market prices at the time of the sale